Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication-Reference-Cited by-同舟云学术

Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication

Published:2019-07 Issue:7 Volume:21 Page:945-947
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ederhy Stephane¹,Dolladille Charles²³,Thuny Franck⁴⁵⁶,Alexandre Joachim²,Cohen Ariel¹

Affiliation:

1. Assistance Publique‐Hôpitaux de Paris, Hôpital Saint AntoineDepartment of Cardiology Paris France; INSERM U 856, Paris, France and UNICO APHP.6 Cardio‐oncology Program

2. Department of PharmacologyCHU Caen, PICARO Cardio‐Oncology Programme Caen France

3. EA 4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie‐Reperfusion MyocardiqueNormandie University, UNICAEN Caen France

4. Mediterranean University Cardio‐Oncology Centre (Medi‐CO centre); Unit of Heart Failure and Valve Heart Diseases (UNIV); Department of CardiologyAix‐Marseille University, Assistance Publique‐Hôpitaux de Marseille, Nord Hospital Marseille France

5. Centre for CardioVascular and Nutrition research (C2VN)Aix‐Marseille University Marseille France

6. Assistance Publique‐Hôpitaux de Marseille, Oncosafety Network of the Early Phases Cancer Trials Center (CLIP²)Aix‐Marseille University Marseille France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1497

Reference5 articles.

1. Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature

2. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity

3. Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors

4. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database

5. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology;European Journal of Heart Failure;2024-08

2. Takotsubo syndrome as an outcome of the use of checkpoint inhibitor therapy in patients with COVID-19;Biochemical Pharmacology;2024-08

3. Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure;Nature Reviews Cardiology;2024-01-26

4. A contemporary update on cancer and takotsubo syndrome;Frontiers in Cardiovascular Medicine;2024-01-08

5. The Immunology of Takotsubo Syndrome;Frontiers in Immunology;2023-10-06